BOSTON– Charles River Associates (NASDAQ: CRAI), a global provider of economic, financial, and management consulting services, announced Tuesday that Frances Hendry has joined the firm as a vice president in its Life Sciences Practice.
“I am pleased to welcome Frances to CRA,” said Paul Maleh, president and CEO of Charles River Associates. “She is an experienced consultant with a background in managing high-performing teams to deliver meaningful business results for life sciences clients.”
Hendry brings extensive experience in advising pharmaceutical companies on new product launches and portfolio optimization. She previously served as vice president at a healthcare consulting and advisory firm specializing in strategy, policy, and data analysis, where she managed client relationships, drove key account growth, and supported business development. Earlier in her career, she held senior roles at a U.K.-based marketing consultancy focused on healthcare and pharmaceuticals.
“Frances is an accomplished team leader with expertise in helping pharmaceutical companies bring new products to market and optimize their product portfolios,” said Dr. Gregory K. Bell, group vice president and leader of CRA’s Life Sciences Practice. “Moreover, she shares our approach to building strong, trusted client relationships. We look forward to working with her and leveraging her strengths across our engagements.”
Hendry holds an MA in Business Management from Glasgow University, an MSc in Marketing from Edinburgh Napier University, and a Chartered Institute of Marketing Postgraduate Diploma from Cambridge Marketing College.
